{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:05:35Z","timestamp":1787994335421,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06458-y","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T10:45:07Z","timestamp":1766832307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis of EBV and HCMV infections in pediatric heart transplant recipients"],"prefix":"10.1186","volume":"26","author":[{"given":"Fatemeh","family":"Gabeleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi Karbalaie","family":"Niya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Ravanshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"6458_CR1","doi-asserted-by":"publisher","unstructured":"Melero-Ferrer J, Sanchez-Lazaro IJ, Navea-Tejerina A, Almenar-Bonet L, Blanes-Julia M, Martinez-Dolz L, et al. Repeated CMV infection in a heart transplantation patient. Case Rep Transpl. 2012;305920. https:\/\/doi.org\/10.1155\/2012\/305920.","DOI":"10.1155\/2012\/305920"},{"key":"6458_CR2","doi-asserted-by":"publisher","first-page":"1171197","DOI":"10.3389\/fimmu.2023.1171197","volume":"14","author":"A Saldan","year":"2023","unstructured":"Saldan A, Mengoli C, Sgarabotto D, Fedrigo M, Angelini A, Feltrin G, et al. Human cytomegalovirus and Epstein\u2013Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients. Front Immunol. 2023;14:1171197. https:\/\/doi.org\/10.3389\/fimmu.2023.1171197.","journal-title":"Front Immunol"},{"issue":"11suppl1","key":"6458_CR3","doi-asserted-by":"publisher","first-page":"II","DOI":"10.1161\/01.CIR.0000138393.99310.1c","volume":"110","author":"P Petrakopoulou","year":"2004","unstructured":"Petrakopoulou P, K\u00fcbrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation. 2004;110(11suppl1):II\u2013207. https:\/\/doi.org\/10.1161\/01.CIR.0000138393.99310.1c.","journal-title":"Circulation"},{"key":"6458_CR4","doi-asserted-by":"publisher","unstructured":"Immohr MB, Akhyari P, B\u00f6ttger C, Mehdiani A, Dalyanoglu H, Westenfeld R, et al. Cytomegalovirus mismatch after heart transplantation: impact of antiviral prophylaxis and intravenous hyperimmune Globulin. Immun Inflamm Dis. 2021;49. https:\/\/doi.org\/10.1002\/iid3.508.","DOI":"10.1002\/iid3.508"},{"issue":"1","key":"6458_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1321-1","volume":"15","author":"I Johansson","year":"2015","unstructured":"Johansson I, Andersson R, Friman V, Selimovic N, Hanzen L, Nasic S, et al. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients. BMC Infect Dis. 2015;15(1):1\u20139. https:\/\/doi.org\/10.1186\/s12879-015-1321-1.","journal-title":"BMC Infect Dis"},{"key":"6458_CR6","doi-asserted-by":"publisher","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;6102. https:\/\/doi.org\/10.1097\/TP.0000000000002191.","DOI":"10.1097\/TP.0000000000002191"},{"issue":"1","key":"6458_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07853-x","volume":"22","author":"C Ju","year":"2022","unstructured":"Ju C, Wang X, Xu X, Xie S, Cao Q, Lin W, et al. Cytomegalovirus seroprevalence, infection, and disease in Chinese thoracic organ transplant recipients: a retrospective cohort study. BMC Infect Dis. 2022;22(1):1\u20137. https:\/\/doi.org\/10.1186\/s12879-022-07853-x.","journal-title":"BMC Infect Dis"},{"key":"6458_CR8","doi-asserted-by":"publisher","unstructured":"Asleh R, Alnsasra H, Habermann TM, Briasoulis A, Kushwaha SS. Post-transplant lymphoproliferative disorder following cardiac transplantation. Front Cardiovasc Med. 2022;9787975. https:\/\/doi.org\/10.3389\/fcvm.2022.787975.","DOI":"10.3389\/fcvm.2022.787975"},{"key":"6458_CR9","doi-asserted-by":"publisher","unstructured":"Nijland ML, Kersten MJ, Pals ST, Bemelman FJ, Ten Berge IJ. Epstein-Barr Virus\u2013Positive posttransplant lymphoproliferative disease after solid organ transplantation: Pathogenesis, clinical Manifestations, Diagnosis, and management. Transpl Direct. 2015;12. https:\/\/doi.org\/10.1097\/TXD.0000000000000557.","DOI":"10.1097\/TXD.0000000000000557"},{"key":"6458_CR10","doi-asserted-by":"publisher","unstructured":"Gardiner BJ, Bailey JP, Percival MA, Morgan BA, Warner VM, Lee SJ, et al. Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients. Clin Transpl. 2023;637. https:\/\/doi.org\/10.1111\/ctr.14982.","DOI":"10.1111\/ctr.14982"},{"key":"6458_CR11","doi-asserted-by":"publisher","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;933. https:\/\/doi.org\/10.1111\/ctr.14982.","DOI":"10.1111\/ctr.14982"},{"key":"6458_CR12","doi-asserted-by":"publisher","unstructured":"Mabilangan C, Burton C, O\u2019Brien S, Plitt S, Eurich D, Preiksaitis J. Using blood donors and solid organ transplant donors and recipients to estimate the Seroprevalence of cytomegalovirus and Epstein\u2013Barr virus in canada: a cross-sectional study. J Assoc Med Microbiol Infect Dis Can. 2020;35. https:\/\/doi.org\/10.3138\/jammi-2020-0005.","DOI":"10.3138\/jammi-2020-0005"},{"key":"6458_CR13","doi-asserted-by":"publisher","unstructured":"Hernandez C, Mabilangan C, Burton C, Doucette K, Preiksaitis J. Cytomegalovirus transmission in mismatched solid organ transplant recipients: are factors other than anti-viral prophylaxis at play? Am J Transpl. 2021;1221. https:\/\/doi.org\/10.1111\/ajt.16734.","DOI":"10.1111\/ajt.16734"},{"issue":"7","key":"6458_CR14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/ajt.12703","volume":"14","author":"M Morton","year":"2014","unstructured":"Morton M, Coupes B, Roberts SA, Johnson S, Klapper P, Vallely P, Picton M. Epstein\u2013Barr virus infection in adult renal transplant recipients. Am J Transpl. 2014;14(7):1619\u201329.","journal-title":"Am J Transpl"},{"key":"6458_CR15","doi-asserted-by":"publisher","unstructured":"Raymund R, Razonable. Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients. Clin Microbiol Infect. (2023): 29(2023):1144\u20131149. https:\/\/doi.org\/10.1016\/j.cmi.2023.03.020","DOI":"10.1016\/j.cmi.2023.03.020"},{"issue":"2","key":"6458_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/infdis\/jix263","volume":"216","author":"JE Yager","year":"2017","unstructured":"Yager JE, Magaret AS, Kuntz SR, Selke S, Huang M-L, Corey L, et al. Valganciclovir for the suppression of Epstein-Barr virus replication. J Infect Dis. 2017;216(2):198\u2013202. https:\/\/doi.org\/10.1093\/infdis\/jix263.","journal-title":"J Infect Dis"},{"issue":"4","key":"6458_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jcv.2014.01.005","volume":"59","author":"H Gill","year":"2014","unstructured":"Gill H, Hwang Y-Y, Chan TS, Pang AW, Leung AY, Tse E, et al. Valganciclovir suppressed epstein barr virus reactivation during immunosuppression with alemtuzumab. J Clin Virol. 2014;59(4):255\u20138. https:\/\/doi.org\/10.1016\/j.jcv.2014.01.005.","journal-title":"J Clin Virol"},{"issue":"1","key":"6458_CR18","doi-asserted-by":"publisher","first-page":"305920","DOI":"10.1155\/2012\/305920","volume":"2012","author":"J Melero-Ferrer","year":"2012","unstructured":"Melero-Ferrer J, Sanchez-Lazaro IJ, Navea-Tejerina A, Almenar-Bonet L, Blanes-Julia M, Martinez-Dolz L, et al. Repeated CMV infection in a heart transplantation patient. Case Rep \u0652ransplant. 2012;2012(1):305920. https:\/\/doi.org\/10.1155\/2012\/305920.","journal-title":"Case Rep \u0652ransplant"},{"issue":"4","key":"6458_CR19","doi-asserted-by":"publisher","first-page":"100083","DOI":"10.1016\/j.tpr.2021.100083","volume":"6","author":"L-P Kuo","year":"2021","unstructured":"Kuo L-P, Tsai M-T, Kao J-Y, Hu Y-N, Cheng C-F, Chang C-H, et al. Early cytomegalovirus reactivation after heart transplantation: A case report and literature review. Transplantation Rep. 2021;6(4):100083. https:\/\/doi.org\/10.1016\/j.tpr.2021.100083.","journal-title":"Transplantation Rep"},{"issue":"6","key":"6458_CR20","doi-asserted-by":"publisher","first-page":"e14982","DOI":"10.1111\/ctr.14982","volume":"37","author":"BJ Gardiner","year":"2023","unstructured":"Gardiner BJ, Bailey JP, Percival MA, Morgan BA, Warner VM, Lee SJ, et al. Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients. Clin Transpl. 2023;37(6):e14982. https:\/\/doi.org\/10.1111\/ctr.14982.","journal-title":"Clin Transpl"},{"issue":"4","key":"6458_CR21","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/iid3.508","volume":"9","author":"MB Immohr","year":"2021","unstructured":"Immohr MB, Akhyari P, B\u00f6ttger C, Mehdiani A, Dalyanoglu H, Westenfeld R, et al. Cytomegalovirus mismatch after heart transplantation: impact of antiviral prophylaxis and intravenous hyperimmune Globulin. Immun Inflamm Dis. 2021;9(4):1554\u201362. Epub 2021 Sep 15.","journal-title":"Immun Inflamm Dis"},{"key":"6458_CR22","doi-asserted-by":"publisher","unstructured":"Hyun H, Park E, Cho M, Min S-I, Ha J, Kang HJ, et al. Post-transplant lymphoproliferative diseases in pediatric kidney allograft recipients with Epstein-Barr virus viremia. J Korean Med Sci. 2019;34(30). https:\/\/doi.org\/10.3346\/jkms.2019.34.e203.","DOI":"10.3346\/jkms.2019.34.e203"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06458-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06458-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06458-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:49:19Z","timestamp":1770385759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06458-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6458"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06458-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Tarbiat Modares University in the Biomedical Research Ethics Committee with approval ID IR.MODARES.REC.1400.023 and was directed ethically according to the Declaration of Helsinki. All participants signed an informed consent form, and consent was obtained from patients for experimentation on the collected samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"94"}}